Overview
Event Details
Please join Steptoe's Intellectual Property group as we host representatives from the Antibody and Small Molecular Directorates of the European Patent Office (EPO) for a discussion on recent developments in EP case law and new EPO examination initiatives.
Date: Thursday, September 28, 2017
Time: 2:00 p.m. - 3:30 p.m. ET
Featured speakers:
- Klaus-Peter Döpfer, Director, EPO
- Thomas Eijkenboom, Director, EPO
- Oskar Lechner, Examiner, EPO
- Carmen Österle, Examiner, EPO
This webinar will be moderated by Steptoe partner Ying Li.
Topics for discussion will include:
- Updates on examination of antibody epitope claims and humanized antibody claims
- Common issues as to priority entitlement, added subject-matter (claim dependencies, singling out, reference documents, and divisional applications)
- Updates on examination of RNAi claims
- A new decision on technical effects of small molecule drugs
- The EPO’s recent “Early Certainty” initiative
CLE credit is pending in AZ, CA, NY, and VA.
